My watch list  


Companies Vaccines


SIRION Biotech is Europe's leading commercial supplier of viral vectors used for genetic cell modelling, gene target validation and gene therapy- and vaccination studies. Since its foundation in 2007, SIRION’s mission has been to change the paradigm for viral vector supplies. It has the ability to more

Products Vaccines

Next Gen Viral Vectors for Gene Therapy & Novel Vaccines

Viral vectors are one of the top 3 topics in drug development. The discussions center on improved transductions and safety, specifically tissue specificity, titers and purity. SIRION Biotech is in Europe the #1 reference when it comes to sourcing viral vectors due to its experience with more than 500 single projects for more than 150 clients more

News Vaccines

  • WACKER Buys Dutch Biotechnology Plant

    Wacker Chemie AG has acquired a Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines, plus the associated business, from SynCo Bio Luxembourg S.à.r.l.. For WACKER, maintaining SynCo’s existing customer relationships is a top priority. Moreover, WACKER is keeping on S more

  • Sanofi to invest €350 million in Canadian vaccine facility

    Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing public health a more

  • Research offers clues for improved influenza vaccine design

    Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the severity of illness, according to new researchl. Current seasonal influenza vaccines mainly target a different, more abund more

All news on vaccines

Infographics Vaccines

A Summary of Common Vaccine Components

The recent measles outbreak in the US has once again provoked discussion over vaccinations, and why some parents choose not to vaccinate their children despite the benefits of doing so. Whilst not the only factor, part of the blame lies with misinformation about the chemical composition of vaccines more

Events Vaccines

01-06 – 04-06
Nassau, BS

Targeting Therapy of Alzheimer’s and Related Neurodegenerative Diseases

Alzheimer’s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide. Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since

10-06 – 15-06
Newport, US

Biology of Host-Parasite Interactions

The 2018 GRC on the Biology of Host-Parasite Interactions is focused on new molecular and translational advances in parasitic diseases. The conference will emphasize the fundamental biology of a wide range of human and veterinarian pathogens that cause malaria, toxoplasmosis, trypanosomiasis, leishm

10-06 – 15-06
West Dover, US

Immunochemistry and Immunobiology

The field of immunology witnesses a period of extraordinary and unprecedented discovery and advancement in virtually every aspect of basic and clinical research. These progresses are in part the result of technological advances which enable us to quantitatively and comprehensively measure the immune

All events on vaccines

Job offers Vaccines

  • Manager Regulatory Affairs (f/m)

    CureVac AG is a biopharmaceutical company researching, developing and producing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on innovative cancer immunotherapies and prophylactic vaccines. Currently, about 340 RNA people are striving to achieve our main goal: To bring more

Publications Vaccines

All publications on vaccines

Market studies Vaccines

  • Vaccines - Senegal

    This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for vaccines in Senegal. The analysis provides essential market information for decision-makers including:   * Overall market value for vaccines in Senegal * Overall market volume for more

  • iBio, Inc. (NYSE ) - Financial and Strategic SWOT Analysis Review

    iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more

  • Iran Pharmaceuticals and Healthcare Report Q2 2012

    BMI View: We continue viewing Iran as one of the less attractive regional markets. Imposition of more stringent international sanctions, rampant inflation, and the loss of confidence in the Iranian rial weigh heavily on consumption and investment patterns, and also on government revenues and the aut more

All market studies on vaccines

Timeline of vaccines

Timeline of vaccines This is a timeline of the development of prophylactic human vaccine s. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE